Evidence map›Paper›PMID 25069981›Full record

ArticleInfection and immunity2014

Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Karen M Scanlon, Yael Gau, Jingsong Zhu, Ciaran Skerry, Susan M Wall, Manoocher Soleimani, Nicholas H Carbonetti

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Solute Carrier Family 26 Member 4 (SLC26A4), A Potential Therapeutic Target for Asthma.Journal of respiratory biology and translational medicine · 2024
    Article
  5. Article
  6. SLC26 Anion Transporters.Handbook of experimental pharmacology · 2024
    Review
  7. DNA-Dependent Interferon Induction and Lung Inflammation inJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Age-Dependent Effects of Type I and Type III IFNs in the Pathogenesis ofJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Karen M ScanlonDepartment of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, USA.
Yael GauDepartment of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, USA.
Jingsong ZhuDepartment of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, USA.
Ciaran SkerryDepartment of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, USA.
Susan M WallDepartment of Medicine, Renal Division, Emory University School of Medicine, Atlanta, Georgia, USA.
Manoocher SoleimaniDepartment of Medicine, University of Cincinnati, Research Services, Veterans Affairs Medical Center, Cincinnati, Ohio, USA.
Nicholas H CarbonettiDepartment of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, USA ncarbonetti@som.umaryland.edu.
University of Maryland, Baltimore · USEmory University · USUniversity of Cincinnati · US

Funding

Exacerbation of pertussis airway inflammation and pathology by pertussis toxinR01AI101055 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CARBONETTI, NICHOLAS H · 2013 to 2017
$1.9M
Exacerbation of pertussis airway inflammation and pathology by pertussis toxinR56AI101055 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CARBONETTI, NICHOLAS H · 2012 to 2012
$401k
NIAID NIH HHS AI-101055NIAID NIH HHS R01 AI101055NIAID NIH HHS R56 AI101055
6 · The paper itself

Abstract

Pertussis disease, characterized by severe and prolonged coughing episodes, can progress to a critical stage with pulmonary inflammation and death in young infants. However, there are currently no effective treatments for pertussis. We previously studied the role of pertussis toxin (PT), an important Bordetella pertussis virulence factor, in lung transcriptional responses to B. pertussis infection in mouse models. One of the genes most highly upregulated in a PT-dependent manner encodes an epithelial transporter of bicarbonate, chloride, and thiocyanate, named pendrin, that contributes to asthma pathology. In this study, we found that pendrin expression is upregulated at both gene and protein levels in the lungs of B. pertussis-infected mice. Pendrin upregulation is associated with PT production by the bacteria and with interleukin-17A (IL-17A) production by the host. B. pertussis-infected pendrin knockout (KO) mice had higher lung bacterial loads than infected pendrin-expressing mice but had significantly reduced levels of lung inflammatory pathology. However, reduced pathology did not correlate with reduced inflammatory cytokine expression. Infected pendrin KO mice had higher levels of inflammatory cytokines and chemokines than infected pendrin-expressing mice, suggesting that these inflammatory mediators are less active in the airways in the absence of pendrin. In addition, treatment of B. pertussis-infected mice with the carbonic anhydrase inhibitor acetazolamide reduced lung inflammatory pathology without affecting pendrin synthesis or bacterial loads. Together these data suggest that PT contributes to pertussis pathology through the upregulation of pendrin, which promotes conditions favoring inflammatory pathology. Therefore, pendrin may represent a novel therapeutic target for treatment of pertussis disease.

Indexed as

Host-Pathogen InteractionsAnimalsAnion Transport ProteinsBacterial LoadBordetella pertussisDisease Models, AnimalGene Expression ProfilingGene Knockout TechniquesHumansInfantInterleukin-17LungMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutAnion Transport ProteinsInterleukin-17Pertussis ToxinSlc26a4 protein, mouseSulfate Transporters

Identifiers

PMID25069981
PMCPMC4187853
OpenAlexW2153520219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.